MedPath

Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy

Not Applicable
Recruiting
Conditions
Pediatric Cancer Patients
Interventions
Radiation: Proton therapy
Registration Number
NCT02644993
Lead Sponsor
Samsung Medical Center
Brief Summary

The study aim of this study is to evaluate the effect of proton therapy on quality of life and long-term normal tissue toxicities of the pediatric cancer patients. Based on these results, the predictive model of long-term normal tissue toxicities, survival, and quality of life could be recognized. Risk-adapted treatment strategy based on the predictive model in pediatric cancer patients could be established.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • less than 18 years of age
  • patient who is planned to receive proton therapy at Samsung Medical Center
  • Informed consent
Read More
Exclusion Criteria
  • Refuse to participate this cohort study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Proton beam therapyProton therapy-
Primary Outcome Measures
NameTimeMethod
Quality of Life Questionnairewithin 2 weeks before proton beam therapy
Secondary Outcome Measures
NameTimeMethod
Quality of Life Questionnaire10 years after proton beam therapy
Adverse event10 years after proton beam therapy
Quality of Life Questionnaire baselinewithin 1 week before proton beam therapy completion

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath